Use your antibodies-online credentials, if available.
Il n’y a pas de produits dans votre liste de comparaison.
Votre panier est vide.
Afficher toutes les espèces
Afficher tous les synonymes
Sélectionnez vos espèces et l'application
anti-Mouse (Murine) PDGFRA Anticorps:
anti-Rat (Rattus) PDGFRA Anticorps:
anti-Human PDGFRA Anticorps:
Vous arrivez à notre recherche pré-filtrée.
Human Monoclonal PDGFRA Primary Antibody pour FACS, IP - ABIN4900645
Velghe, Van Cauwenberghe, Polyansky, Chand, Montano-Almendras, Charni, Hallberg, Essaghir, Demoulin: PDGFRA alterations in cancer: characterization of a gain-of-function V536E transmembrane mutant as well as loss-of-function and passenger mutations. dans Oncogene 2014
Show all 6 Pubmed References
Human Monoclonal PDGFRA Primary Antibody pour FACS - ABIN4898823
Uosaki, Andersen, Shenje, Fernandez, Christiansen, Kwon: Direct contact with endoderm-like cells efficiently induces cardiac progenitors from mouse and human pluripotent stem cells. dans PLoS ONE 2012
Show all 4 Pubmed References
Mouse (Murine) Monoclonal PDGFRA Primary Antibody pour FACS - ABIN1176995
Fruttiger, Calver, Krüger, Mudhar, Michalovich, Takakura, Nishikawa, Richardson: PDGF mediates a neuron-astrocyte interaction in the developing retina. dans Neuron 1997
Show all 3 Pubmed References
Human Polyclonal PDGFRA Primary Antibody pour WB - ABIN271391
Zheng, Ishii, Tokunaga, Hamashima, Shen, Zhao, Ishizawa, Fujimori, Nabeshima, Mori, Kondo, Sasahara: Neuroprotective effects of PDGF against oxidative stress and the signaling pathway involved. dans Journal of neuroscience research 2010
Show all 3 Pubmed References
Human Monoclonal PDGFRA Primary Antibody pour FACS - ABIN4898820
Craft, Rockel, Nartiss, Kandel, Alman, Keller: Generation of articular chondrocytes from human pluripotent stem cells. dans Nature biotechnology 2015
Show all 3 Pubmed References
Human Polyclonal PDGFRA Primary Antibody pour PLA, WB - ABIN518742
Moroncini, Grieco, Nacci, Paolini, Tonnini, Pozniak, Cuccioloni, Mozzicafreddo, Svegliati, Angeletti, Kazlauskas, Avvedimento, Funaro, Gabrielli: Epitope Specificity Determines Pathogenicity and Detectability of Anti-Platelet-Derived Growth Factor Receptor α Autoantibodies in Systemic Sclerosis. dans Arthritis & rheumatology (Hoboken, N.J.) 2015
Human Monoclonal PDGFRA Primary Antibody pour PLA, ELISA - ABIN518743
Dugas, Cuellar, Scholze, Ason, Ibrahim, Emery, Zamanian, Foo, McManus, Barres: Dicer1 and miR-219 Are required for normal oligodendrocyte differentiation and myelination. dans Neuron 2010
Human Polyclonal PDGFRA Primary Antibody pour IF (p), IHC (p) - ABIN726620
Hu, Zeng, Jiang, Hu, Meng, Zhu, Mao: The expression of marker for endometrial stem cell and fibrosis was increased in intrauterine adhesious. dans International journal of clinical and experimental pathology 2015
Human Polyclonal PDGFRA Primary Antibody pour IHC (p), WB - ABIN392024
Wilczynski, Chen, Chen, Howell, Shively, Alberts: Expression and mutational analysis of tyrosine kinase receptors c-kit, PDGFRalpha, and PDGFRbeta in ovarian cancers. dans Human pathology 2005
Show all 6 Pubmed References
Mouse (Murine) Polyclonal PDGFRA Primary Antibody pour FACS - ABIN4896885
Min, Jaichander, Sanchez-Ortiz, Bezprozvannaya, Malladi, Cui, Wang, Bassel-Duby, Olson, Liu: Identification of a multipotent Twist2-expressing cell population in the adult heart. dans Proceedings of the National Academy of Sciences of the United States of America 2018
PDGFRA is not essential for the derivation and maintenance of extraembryonic endoderm stem (XEN) cell lines .
loss of Pdgfra in endothelial-derived (Montrer MED28 Anticorps) mesenchyme in the outflow tract endocardial cushions leads to a secondary defect in neural crest migration during development.
Investigated the developmental process of mesenchymal stem cells (MSCs) in embryos using the gene Pdgfra as a marker. We traced cells expressing Pdgfra and other genes (brachyury (Montrer TBX1 Anticorps), Sox1 (Montrer SOX1 Anticorps) and Pmx1 (Montrer PRRX1 Anticorps)) in various mutant embryos until the adult stage. Embryonic MSCs emerge in waves and almost all adult bone marrow MSCs and white adipose tissue MSCs originate from mesoderm and embryonic Pdgfralpha-positive cells.
PDGFRalpha/PDGFRbeta signaling balance determines progenitor commitment to beige (Montrer LYST Anticorps) (PDGFRalpha) or white (PDGFRbeta) adipogenesis.
Spreading of PDGFR-alpha-deficient lung fibroblasts was insensitive to increased rigidity, and their migration was not reduced by Rac1 (Montrer RAC1 Anticorps)-guanine exchange factor (GEF (Montrer ARHGEF2 Anticorps))-inhibition. PDGFR-alpha-expressing fibroblasts migrated toward stiffer regions within two-dimensional substrates by increasing migrational persistence (durotaxis).
Histone H3.3K27M and Trp53 (Montrer TP53 Anticorps) loss and PDGFRA overexpression accelerates disease onset and increases tumor invasion.
The diabetes-induced increase in PDGFRalpha+ cells may be mediated by FOXO3 up-regulation via the inhibition of the PI3K/Akt signaling pathway in STZ-induced diabetic mice.
Constitutive activation of PDGFRalpha leads to expansion of cartilage underlying the coronal sutures, which contribute to suture closure through endochondral ossification, in a process regulated in part by PI3K/AKT (Montrer AKT1 Anticorps) signaling.
OLIG2 (Montrer OLIG2 Anticorps) modulates growth factor signaling in two distinct populations of glioma stem cells, characterized by expression of either the epidermal growth factor receptor (EGFR (Montrer EGFR Anticorps)) or platelet-derived growth factor receptor alpha.
Conditional knockout of Pdgfra in Pdgfra-expressing tissues in mouse embryos at different embryonic days (E9.5 and E10.5) resulted in multiple developmental anomalies of the frontonasal region, the cranium and the abdominal wall musculature. Furthermore, the day at which the Pdgfra is deleted influences the repertoire of the anomalies of the conditional knockout embryos.
High PDGFR (Montrer PDGFRB Anticorps) expression is associated with retinal neovascularization.
In addition to replicating a previously identified genome-wide significant locus for corneal astigmatism near the PDGFRA gene, gene-based analysis identified three novel candidate genes, CLDN7, ACP2, and TNFAIP8L3, that warrant further investigation to understand their role in the pathogenesis of corneal astigmatism. (Meta-analysis)
The present study showed that PDGFRA amplification could be effectively targeted by pazopanib.
KIT and PDGFRA mutations account for 85-90% of GISTs; subsequent genetic studies have led to the identification of mutation/epimutation of additional genes, including the succinate dehydrogenase (SDH (Montrer SDHA Anticorps)) subunit A, B, C, and D genes.
we compared the efficacy of first-line therapy, doxorubicin (DOX), and TRAB in a platelet-derived growth factor receptor-alpha (PDGFRA)-amplified PLPS. METHODS: We used a fresh sample of PLPS tumor derived from a 68-year-old male patient diagnosed with a recurrent Pleomorphic liposarcoma
PDGFRA D842V mutant binds imatinib with lower affinity with respect to wild-type structure, showing higher stability during the interaction with other type I TKIs (like crenolanib).
Altered SK3 channel expression observed in PDGFRalpha(+) cells in UPJ obstruction suggests that the impairment of SK3 activity across the UPJ may perturb upper urinary tract peristalsis in this urological condition
None of the 16 analyzable tumors showed mutations in PDGFRA. Thus, PDGFRA mutations probably do not play an important role in the development of sporadic lipomas of the intestines
Whole transcriptome sequencing followed by pathway analysis indicated that STXBP4 (Montrer STXBP4 Anticorps) is involved in functional gene networks that regulate cell growth, proliferation, cell death, and survival in cancer. Platelet-derived growth factor receptor alpha (PDGFRalpha) was a key downstream mediator of STXBP4 (Montrer STXBP4 Anticorps) function. In line with this, shRNA mediated STXBP4 (Montrer STXBP4 Anticorps) and PDGFRA knockdown suppressed tumor growth in soft-agar and xenograft ...
We report a unique case of an SDH (Montrer SARDH Anticorps)-deficient GIST case with an activating PDGFRA mutation. Oncogenic mutations in GIST are generally mutually exclusive; however documented exceptions exist which may have diagnostic and therapeutic implications.
Case Report: concurrent development of myeloproliferative hypereosinophilic syndrome and lymphomatoid papulosis associated with FIP1L1 (Montrer FIP1L1 Anticorps)-PDGFRA gene fusion.
This gene encodes a cell surface tyrosine kinase receptor for members of the platelet-derived growth factor family. These growth factors are mitogens for cells of mesenchymal origin. The identity of the growth factor bound to a receptor monomer determines whether the functional receptor is a homodimer or a heterodimer, composed of both platelet-derived growth factor receptor alpha and beta polypeptides. Studies suggest that this gene plays a role in organ development, wound healing, and tumor progression. Mutations in this gene have been associated with idiopathic hypereosinophilic syndrome, somatic and familial gastrointestinal stromal tumors, and a variety of other cancers.
platelet-derived growth factor receptor, alpha polypeptide
, alpha-type platelet-derived growth factor receptor-like
, Alpha platelet-derived growth factor receptor precursor (PDGF-R-alpha)
, CD140 antigen-like family member A
, PDGF alpha chain
, alpha-type platelet-derived growth factor receptor
, platelet-derived growth factor alpha receptor
, platelet-derived growth factor receptor alpha
, alpha platelet-derived growth factor receptor
, CD140a antigen
, PDGFRA/BCR fusion
, platelet-derived growth factor receptor 2
, rearranged-in-hypereosinophilia-platelet derived growth factor receptor alpha fusion protein
, tyrosine kinase PDGFR